 MALVERN, Pa., May 13, 2021 GLOBE NEWSWIRE -- TELA Bio, Inc. TELA Nasdaq: TELA, a commercial stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today reported financial results for the first quarter ended March 31, 2021. 